Global Biodesign SComm
The score of Global Biodesign shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2024
Change 2022 → 2024: Equity +3780 % Total assets -31 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Global Biodesign's annual accounts
Filed annual accounts
- Year ended 31 Dec 2024filed on 28 Sep 2025
- Year ended 31 Dec 2023filed on 22 Jul 2024
- Year ended 31 Dec 2022filed on 11 Jul 2023
Global Biodesign's financial analysis
- Solvency14.8%sector median: 30.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Global Biodesign
Global Biodesign's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0761.814.640
- VAT number
- BE0761814640
- Peppol
- Registered · 0208:0761814640 · as of 10 Nov 2026
- Legal form
- SComm
- Incorporated
- 20 Jan 2021
- Registered office
- 1180 Uccle
- Latest accounts
- 2024 · filed on 28 Sep 2025
- Activity
- Support activities for crop production (NACE 01610)
Global Biodesign (SComm) has been based in Uccle since 2021, active in: support activities for crop production. For 2024, it reports a net profit of 1,011 € and equity of 10,483 €; its revenue is not published. Its solvency stands at 14.8%, below the median of its sector (30.6%).
Companies similar to Global Biodesign
Companies in the same business, of comparable size and area, outside its group.
- DT Research & Development Research and experimental development on natural sciences and engineering Brussels · balance sheet 7,943 €
- S.Q.L. Computer consultancy and computer facilities management activities Ans · balance sheet 101,381 €
- Logibot Research and experimental development on natural sciences and engineering Huldenberg · balance sheet 117,581 €
- Cubatik Research and experimental development on natural sciences and engineering Crisnée · balance sheet 151,712 €
- InnoC Business and other management consultancy activities Rixensart · balance sheet 151,744 €
- Altvea Business and other management consultancy activities Trooz · balance sheet 68,069 €
- icode Research and experimental development on natural sciences and engineering Walhain · balance sheet 79,376 €
- Arcturian Computer consultancy and computer facilities management activities Auderghem · balance sheet 68,146 €
Frequently asked questions about Global Biodesign
What is the revenue of Global Biodesign?
Global Biodesign files its accounts in a format where revenue is optional: it is not published for 2024.
What is the VAT number of Global Biodesign?
In Belgium, the VAT number is the company number prefixed with BE: BE0761814640 for Global Biodesign, if the company is VAT-registered. Its company number (CBE) is 0761.814.640.
Where is the registered office of Global Biodesign?
According to the CBE register, the registered office of Global Biodesign is in 1180 Uccle.
What is the equity of Global Biodesign?
At the close of the 2024 financial year, the equity of Global Biodesign amounts to 10,483 €, a solvency of 14.8% of total assets.
Who manages Global Biodesign?
The register lists 1 active mandates at Global Biodesign. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Global Biodesign
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →